
Strategic MSAT leader with 10+ years of experience driving technology transfers, process scale-up, and lifecycle support for cell and gene therapies. Proven record in regulatory-facing role, PPQ execution, and cross-functional leadership across CDMOs, QA/QC, and regulatory affairs. Trusted subject matter expert (SME) in viral vector and CAR-T platforms. Recognized for enabling clinical and commercial readiness through robust CMC execution and operational excellence.